The coexistence of cancer and heart disease, both prominent causes of illness and death, is further exacerbated by the detrimental impact of chemotherapy. Anthracycline-induced …
L Wang, F Qi, L Bi, J Yan, X Han, Y Wang… - Biomaterials …, 2023 - pubs.rsc.org
Bladder cancer (BC), such as non-muscle invasive bladder cancer (NMIBC), has a significantly high recurrence rate even after intravesical therapy because traditional …
Pirarubicin (PRB) is an anthracycline antibiotic that has shown equal or superior cytotoxicity compared to doxorubicin. However, the detailed toxicological profile for Pirarubicin has not …
OA El-Kawy, HA Shweeta, KM Attallah - Applied Radiation and Isotopes, 2022 - Elsevier
Brain cancer is a challenging disease to treat using conventional approaches. The present investigation aimed to develop a radiopharmaceutical targeting brain cancer based on …
OA El-Kawy, IT Ibrahim, HA Shewatah… - International Journal of …, 2023 - Taylor & Francis
Purpose The present investigation aims to develop and evaluate a radiopharmaceutical for targeting and assessing β-cells mass based on gliclazide, an antidiabetic drug that …
BM Essa, AA Selim, OA El-Kawy… - International journal of …, 2022 - Taylor & Francis
Background Nanomedicine offers great potential for scintigraphic diagnostic imaging with lower risk and higher quality compared to other traditional techniques. Objectives This work …
Introduction Alpha-mangostin (AM), the most representative xanthone derivative isolated from the rind of the Purple Mangosteen (Garcinia mangostana Linn), has been reported …
Pirarubicin attracted considerable attention in clinical studies because of its high therapeutic efficacy and reduced toxicity in comparison with other anthracyclines. Nevertheless,~ 30 …
A Jain, T Das - Journal of Radioanalytical and Nuclear Chemistry, 2024 - Springer
The use of radiolabeled chemotherapeutics is an exciting prospect in the management of cancer, as lethal cytotoxic radiation dose can be delivered to the cancerous lesions by using …